Nuclear medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease.
Market trend Snapshot
Global Nuclear Medicine market was valued at 7,286 million USD in 2019 and projected to reach 14,565 million USD by 2026, growing at a CAGR of 10.40%. This report provides comprehensive and in-depth analysis and prediction of the Nuclear Medicine industry.
The increasing incidence of cancer and cardiovascular disorders, raising awareness about nuclear medicine, technological advancements, increasing healthcare expenditure, and increasing demand of radiopharmaceuticals in emerging economies are the major factors that propelling the Nuclear Medicine market growth. Furthermore, the need for early and accurate diagnostic methods, coupled with the growing demand for better therapies are some of the other crucial factors that expected to give impetus to the market growth. However, stringent regulatory approvals, high cost of devices using radioisotopes, the short half-life of radiopharmaceuticals, and availability of conventional diagnostics procedures are factors that projected to hamper the market growth.
From Base year 2018 to forecast year 2026
Get FREE Sample of Nuclear Medicine Market Report at:
Key Market Players Profile
Key market players covered in the report such as Advanced Accelerator Applications S.A., Ashby Gorman Baker Ltd, Bayer Healthcare, Bracco Imaging S.P.A, Cardinal Health, Digirad, Eczcibasi-Monrol Nuclear Products, GE Healthcare, IBA Molecular Imaging, Lantheus Medical Imaging, Mallinckrodt PLC, Mediso Ltd., Nordion, Inc., Philips Healthcare, and Siemens Healthcare. These players’ market share, revenue, company profile, and SWOT analysis are covered in the Nuclear Medicine report. In the future, production and consumption are estimated to continue developing with a stable growth rate. As a result of meeting the surging demand, more manufacturers are expected to go into this industry.
North America holds the largest Nuclear Medicine market share
The report covers the major countries analysis in North America, Europe, Asia Pacific, and the rest of the world. Furthermore, policy mobilization, social dynamics, development trends, and economic development in these countries are also taken into consideration.
North America was the leading market with a share of 31.52% and expected to maintain dominance during the forecast period. This can be attributed to advanced healthcare infrastructure in the region, especially in the U.S. Rising burden of cancer and various cardiovascular disorders is also a high impact rendering factor driving the market.
The Asia Pacific was the second largest market with a share of 28.63% and projected to be the fastest growing region over the predicted years. Demand for nuclear medicine is increasing in emerging markets such as China and India due to rising disposable income, improving healthcare standards, and favorable reforms in foreign policies.
Europe occupied a share of 25.96% in 2018 and also anticipated to witness stable growth during the coming years.
Nuclear Medicine Type and Application Sketch
By type
Diagnostic segment occupied the major share in 2018. It includes cardiology, neurology, oncology, thyroid, and lymphoma. Oncology is the largest segment by diagnostic application, while cardiology is expected to register strong growth over the forecast period.
Usage of radioactive elements is effective but equally risky to patients as well as operators of these devices. With the introduction of advanced protective measures and growing awareness regarding the procedures, this segment is poised to grow rapidly over the coming years.
By application
Get FREE Sample of Nuclear Medicine Market Report at:
Nuclear Medicine Report provides
Table of Content
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine Market
…
2 Market Trends and Competitive Landscape
3 Segmentation of Nuclear Medicine Market by Types
4 Segmentation of Nuclear Medicine Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Nuclear Medicine Market in Major Countries
7 North America Nuclear Medicine Landscape Analysis
8 Europe Nuclear Medicine Landscape Analysis
9 Asia Pacific Nuclear Medicine Landscape Analysis
10 Latin America, Middle East & Africa Nuclear Medicine Landscape Analysis
11 Major Players Profile
11.1 Advanced Accelerator Applications S.A.
11.1.1 Advanced Accelerator Applications S.A. Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Ashby Gorman Baker Ltd
11.3 Bayer Healthcare
11.4 Bracco Imaging S.P.A
11.5 Cardinal Health
11.6 Digirad
11.7 Eczcibasi-Monrol Nuclear Products
11.8 GE Healthcare
11.9 IBA Molecular Imaging
11.10 Lantheus Medical Imaging
11.11 Mallinckrodt PLC
11.12 Mediso Ltd.
11.13 Nordion, Inc.
11.14 Philips Healthcare
11.15 Siemens Healthcare
…
Target Audience:
Get FREE Sample of Nuclear Medicine Market Report at:
Contact
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Name: Rebecca Hall
Phone: + 1 (347) 467 7721
Email: info@globalmarketmonitor.com
Web Site: https://www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.
Chinese